Oxidative modulation of cyclic AMP-dependent protein kinase in human fibroblasts: Possible role in psoriasis

Free Radical Biology and Medicine

Volumn 22, Issue 4, 1997, Pages 623-632

  Raynaud, Françoise ^a   Evain Brion, Danièle ^a   Gerbaud, Pascale ^a   Marciano, Denis ^a   Gorin, Isabelle ^b   Liapi, Charis ^c   Anderson, Wayne B ^c  

^a INSERM   (France)

^b Paris Descartes University   (France)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

cAMP dependent protein kinase; Fibroblasts; Hydrogen peroxide; Oxidative modulation; Psoriasis

Indexed keywords

8 AZIDOADENOSINE 3',5' PHOSPHATE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DERIVATIVE; HYDROGEN PEROXIDE; MANNITOL; OXYGEN RADICAL; PHOSPHORUS 32; PROTEIN SUBUNIT; REGULATOR PROTEIN; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOLOGY; OXIDATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN MODIFICATION; PSORIASIS; SKIN FIBROBLAST;

BOVINAE;

EID: 0031030064     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(96)00353-X     Document Type: Article

References (68)

1. Krueger G. G., Bergsresser P. R., Lowe N. J., Voorhees J. J., Weinstein G. D. Psoriasis. J. Am. Acad. Dermatol. 11:1984;937-947.
2. Barker J. N. W. N. The pathophysiology of psoriasis. Lancet. 338:1991;227-230.
3. Saiag P., Coulomb B., Lebreton C., Bell E., Dubertret L. Psoriatic fibroblasts induce hyperproliferation of normal keratinocytes in a skin equivalent model in vitro. Science. 230:1985;669-672.
4. Evain-Brion D., Raynaud F., Plet A., Laurent P., Leduc B., Anderson W. B. Deficiency of cyclic AMP-dependent protein kinases in human psoriasis. Proc. Natl. Acad. Sci. USA. 83:1986;5272-5276.
5. Raynaud F., Gerbaud P., Enjolras O., Gorin I., Donnadieu M., Anderson W. B., Evain-Brion D. A cAMP binding abnormality in psoriasis. Lancet. i:1989;1153-1156.
6. Rubin C. S., Rosen O. M. Protein phosphorylation. Annu. Rev. Biochem. 44:1976;831-887.
7. Bechtel P. J., Beavo J. A., Krebs E. G. Purification and characterization of catalytic subunit of skeletal muscle adenosine 3′5′-monophosphate-dependent protein kinase. J. Biol. Chem. 252:1977;2691-2697.
8. Taylor S. S., Buechler J. A., Yonemoto W. cAMP-dependent protein kinase: Framework for a diverse family of regulatory enzymes. Annu. Rev. Biochem. 59:1990;971-1005.
9. Skalhegg B. S., Landmark B., Foss K. B., Lohman S. M., Hansson V., Lea T., Jahnsen T. Identification, purification, and characterization of subunits of cAMP-dependent protein kinase in human testis. Reverse mobilities of human RIIα and RIIβ on sodium dodecyl sulfate-polyacrylamide gel electrophoresis compared with rat and bovine RIIs. J. Biol. Chem. 267:1992;5374-5379.
10. Scott J. D. Subcellular localization of type II. NIPS. 7:1992;143-148.
11. Walter U., Uno I., Liu A. Y. C., Greengard P. Identification, characterization and quantitative measurements of cAMP receptor proteins in cytosol of various tissues using a photoaffinity ligand. J. Biol. Chem. 252:1977;6494-6500.
12. Raynaud F., Leduc C., Anderson W. B., Evain-Brion D. Retinoid treatment of human psoriatic fibroblasts increases cyclic AMP-dependent protein kinase levels. J. Invest. Dermatol. 89:1987;105-110.
13. Petkovich M., Brand N. J., Kurst A., Chambon P. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature. 330:1987;144-150.
14. Giguere V., Ong E. S., Segui P., Evans R. M. Identification of a receptor for the morphogen retinoic acid. Nature. 330:1987;624-629.
15. Burton G. W., Ingold K. U. Beta-carotene: An unusual type of lipid antioxidant. Science. 224:1984;569-573.
16. Samokyszyn V. M., Marnett L. J. Inhibition of liver microsomal lipid peroxydation by 13-cis retinoid. Free Radic. Biol. Med. 8:1990;491-496.
17. Geesin J. C., Gordon J. S., Berg R. A. Retinoids affect collagen synthesis through inhibition of ascorbate-induced lipid peroxidation in cultured human fibroblasts. Arch. Biochem. Biophys. 278:1990;350-355.
18. Raynaud F., Gerbaud P., Bouloc A., Gorin I., Anderson W. B., Evain-Brion D. Rapid effect of treatment of psoriatic erythrocytes with synthetic retinoid acitretin to increase 8-azido cyclic AMP binding to the RI regulatory subunit. J. Invest. Dermatol. 100:1993;77-81.
19. Gundimela U., Hara S. K., Anderson W. B., Gopalakrishna R. Retinoids inhibit the oxidative modification of protein kinase C induced by oxidant tumor promoters. Arch. Biochem. Biophys. 300:1993;526-530.
20. Laemli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
21. Willson R. L. Free radicals and tissue damage: Mechanistic evidence from radiation studies. Slater T. L. Biochemical mechanisms of liver injury. 1978;123-224 Academic Press, New York.
22. Fricke H., Hart F. J. Chemical dosimetry. Attix F. H., Roesh W. Radiation dosimetry. 1966;167-239 Academic Press, New York.
23. Bohlen P., Stein S., Dairman W., Udenfriend S. Fluorometric assay of proteins in the nanogram range. Arch. Biochem. Biophys. 155:1973;213-220.
24. Halliwell B. Oxidants and human disease: Some new concepts. FASEB J. 1:1987;358-364.
25. Stadtman E. R., Oliver C. N., Levine R. L., Fucci L., Rivett A. J. Implication of protein oxidation in protein turnover, aging, and oxygen toxicity. Basic Life Sci. 49:1988;331-339.
26. Matsubara T., Ziff M. Increased superoxide anion release from human endothelial cells in response to cytokines. J. Immunol. 137:1986;3295-3298.
27. Meier B. H. H., Radeke S., Selle M., Young H., Sies K., Resh H., Habermehl G. G. Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumor necrosis factor. Biochem. J. 263:1989;539-545.
28. Zoccarato F., Deana R., Cavallini L., Alexandre A. Generation of hydrogen peroxide by cerebral cortex synaptosomes stimulation by ionomycin and plasma membrane depolarization. Eur. J. Biochem. 180:1989;473-478.
29. Garrett I. R., Boyce B. F., Oreffo R. O. C., Bonewald L., Poser J., Mundy G. R. Oxygen-derived free radicals stimulate osteoclastic bone in rodent bone in vitro and in vivo. J. Clin. Invest. 85:1990;632-639.
30. 2 for platelet-derived growth factor signal transduction. Science. 270:1995;296-299.
31. Schreck R., Rieber P., Baeuerle P. A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF- χB transcription factor and HIV-1. EMBO J. 10:1991;2247-2258.
32. Stadtman E. R. Oxidation of proteins by mixed function oxidation systems: Implication in protein turnover, ageing and neutrophil function. Trends Biol. Sci. 11:1986;11-12.
33. Gopalakrishna R., Anderson W. B. Susceptibility of protein kinase C to oxidative inactivation: Loss of both phosphotransferase activity and phorbol ester binding. FEBS Lett. 225:1987;233-237.
34. Whisler R. L., Goyette M. A., Grants I. S., Newhouse Y. G. Sublethal levels of oxidant stress stimulate multiple serine/threonine kinases and suppress protein phosphatases in jurkat T cells. Arch. Biochem. Biophys. 319:1995;23-35.
35. Abate C., Patel L., Rauscher F. J., Curran T. Redox regulation of Fos and jun DNA-binding activity in vitro. Science. 249:1990;1157-1161.
36. Chevalier M., Lin E. C., Levine R. L. Hydrogen peroxide mediates the oxidative inactivation of enzymes following the switch from anaerobic to aerobic metabolism in Klebsiella pneumoniae. J. Biol. Chem. 265:1990;42-46.
37. Landgraf W., Regulla S., Meyer H. E., Hofman F. Oxidation of cysteines activates cGMP-dependent protein kinase. J. Biol. Chem. 266:1991;16305-16311.
38. Schreck R., Baeuerle P. A. A role for oxygen radicals as second messengers. Trends Cell Biol. 1:1991;39-42.
39. Ueda M. F., Robinson W., Smith M., Kono T. Effects of divalent cations on the regulation of insulin sensitive glucose transport and cAMP phosphodiesterase in adipocytes; Insulin-like effects of divalent cations. J. Biol. Chem. 259:1984;9520-9525.
40. Thomas G., Ramwell P. Induction of vascular relaxation by hydrogen peroxides. Biochem. Biophys. Res. Commun. 139:1986;102-108.
41. 2+ and phospholipid-independent activation of protein kinase C by selective oxidative modification of regulatory domain. Proc. Natl. Acad. Sci. USA. 86:1989;6758-6762.
42. Gopalakrishna R., Anderson W. B. Reversible oxidative activation and inactivation of protein kinase C by the mitogen/tumor promoter periodate. Arch. Biochem. Biophys. 285:1991;382-387.
43. Krebs E. G. Phosphorylation-dephosphorylation of enzymes. Annu. Rev. Biochem. 48:1979;923-959.
44. Boynton A. L. The role of cyclic AMP in cell proliferation. A critical assessment of the evidence. Adv. Cyclic Nucleotide Res. 15:1983;193-280.
45. Cho-Chung Y. S. Role cAMP receptor proteins in growth, differentiation and suppression of malignancy: New approaches to therapy. Cancer Res. 50:1990;7093-7100.
46. Marx J. Two major signal pathways linked. Science. 262:1993;988.
47. Cook S. J., McCormick F. Inhibition by cAMP of Ras-dependent activation of Raf. Science. 262:1993;1069-1072.
48. + channels of Aplysia sensory neurones in cell-free membrane patches. Nature. 313:1985;392-395.
49. Maurer R. A. Transcriptional regulation of the prolactin gene by ergocryptine cyclic AMP. Nature. 294:1981;94-97.
50. Lee K. A. Transcriptional regulation by cAMP. Curr. Opin. Cell Biol. 3:1991;953-959.
51. McKnight G. S. cAMP second messenger systems. Curr. Opin. Cell Biol. 3:1991;213-217.
52. Yokozaki H., Budillon A., Tortora G., Meissner S., Beaucage S. L., Miki K., Cho-Chung Y. S. An antisense oligodeoxy nucleotide that depletes R alpha subunit of cyclic AMP-dependent protein kinase induces growth inhibition in human cancer cells. Cancer Res. 53:1993;868-872.
53. Nigg E. A., Schäfer G., Hilz H., Eppenberger H. M. cAMP-dependent protein kinase type II is associated with golgi complex and with centrosomes. Cell. 41:1985;1039-1051.
54. Keryer G., Rios R. M., Landmark B. F., Skalhegg B., Lohman S. M., Bornens M. A high affinity binding protein for the regulatory subunit of cAMP-dependent protein kinase II in the centrosome of human cells. Exp. Cell Res. 204:1993;230-240.
55. Theurkauf W. E., Vallee R. B. Molecular characterization of the cAMP dependent protein kinase bound to microtubule-associated protein 2. J. Biol. Chem. 257:1982;3284-3290.
56. Tournier S., Raynaud F., Gerbaud P., Lohmann S. M., Dorée M., Evain-Brion D. Association of type II cAMP-dependent protein kinase with p34cdc2 protein kinase in human fibroblasts. J. Biol. Chem. 266:1991;19018-19022.
57. Lohmann S. M., Walter U. Regulation of the cellular and subcellular concentrations and distribution of cyclic nucleotide-dependent protein kinases. Prot. Phosphoryl. Res. 18:1984;63-102.
58. Halliwell B., Gutteridge J. M. C. Protection against oxidants in biological systems: The superoxide theory of oxygen toxicity. Free radicals in biology and medicine. 1989;86-187 University Press, Oxford.
59. Grossman R. M., Krueger J., Yourish D., Granelli-Piperno A., Murphy D., May L. T., Kupper T. S., Sehgal P. B., Gottlieb A. B. Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc. Natl. Acad. Sci. USA. 86:1989;6367-6373.
60. Ohta Y., Katayama I., Funato T., Yokozeki H., Nishiyama S., Hirano T., Kishimoto T., Nishioka K. In situ expression of messenger RNA of interleukin-1 and interleukin-6 in psoriasis: Interleukin-6 involved in formation of psoriatic lesions. Arch. Dermatol. Res. 283:1991;351-356.
61. Wong G., Goeddel D. Induction of manganous superoxide dismutase by tumor necrosis factor: Possible protective mechanism. Science. 242:1988;941-944.
62. Visner G., Dougall W. C., Wilson J. M., Burr I., Nick H. S. Regulation of manganese superoxide dismutase by lipolysaccharide, interleukin-1 and tumor necrosis factor protein in the active inflammatory response. J. Biol. Chem. 265:1990;2856-2864.
63. Visner G. A., Chesrown S. E., Monnier J., Ryan U. S., Nick H. S. Regulation of manganese superoxide dismutase: IL-1 and TNF induction in pulmonary artery and microvascular endothelial cells. Biochem. Biophys. Res. Commun. 188:1992;453-462.
64. van Baar H., van de Kerkhof P., Schalwijk J., Mier P. Cutaneous superoxide dismutase activity in psoriasis. Br. J. Dermatol. 116:1987;462.
65. Kobayashi T., Matsumoto M., Iizuka H., Suzuki K., Taniguchi N. Superoxide dismutase in psoriasis, squamous cell carcinoma and basal cell epithelioma: An immunohistochemical study. Br. J. Dermatol. 124:1991;555-559.
66. Iizuka H, Asaga H., Kotke K., Iizuka S. Decreased Cu, Zn-superoxide dismutase activity in psoriatic hyperproliferative epidermis. Eur. J. Dermatol. 3:1993;56-58.
67. Löntz W., Sirsjö A., Liu W., Lindberg M., Rollman O., Törmä H. Increased mRNA expression of manganese superoxide dismutase in psoriasis skin lesions and in cultured human keratinocytes exposed to IL- 1β and TNF- α Free Radic. Biol. Med. 18:1995;349-355.
68. Therond, P.; Gerbaud, P. Dimon, S.; Anderson, W. B.; Evain-Brion, D.; Raynaud, F.Antioxidant enzymes in psoriatic fibroblasts and erythrocytes. J. Invest. Dermatol. (in press).